Farnesyltransferase Inhibitor BMS-214662 Induces Apoptosis in Myeloma Cells through PUMA Up-Regulation, Bax and Bak Activation, and Mcl-1 Elimination
暂无分享,去创建一个
Javier Naval | A. Anel | J. Naval | Isabel Marzo | I. Marzo | Alberto Anel | María Gómez-Benito | M. Gómez-Benito
[1] H. Yamaguchi,et al. Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells. , 2002, Cancer research.
[2] L. Boise,et al. R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathways. , 2004, Molecular cancer therapeutics.
[3] M. Kamphuis,et al. Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels. , 2003, Blood.
[4] D. Grandér,et al. Activation of Bak, Bax, and BH3-only Proteins in the Apoptotic Response to Doxorubicin* , 2002, The Journal of Biological Chemistry.
[5] M. Morgan,et al. Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies? , 2000, Blood.
[6] R. Bataille,et al. Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells. , 2002, Blood.
[7] R. Bataille,et al. Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells , 2002, Leukemia.
[8] Masaharu Akiyama,et al. Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications , 2002, Oncogene.
[9] I. Gojo,et al. Myeloid cell factor-1 is a critical survival factor for multiple myeloma. , 2002, Blood.
[10] F. Khuri,et al. Implication of protein kinase B/Akt and Bcl-2/Bcl-XL suppression by the farnesyl transferase inhibitor SCH66336 in apoptosis induction in squamous carcinoma cells. , 2003, Cancer research.
[11] A. Anel,et al. Role of caspases and apoptosis-inducing factor (AIF) in cladribine-induced apoptosis of B cell chronic lymphocytic leukemia , 2002, Leukemia.
[12] R. Bataille,et al. The imbalance between Bim and Mcl‐1 expression controls the survival of human myeloma cells , 2004, European journal of immunology.
[13] D A Scudiero,et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.
[14] F. Lee,et al. Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor. , 2001, Cancer research.
[15] Wenhua Gao,et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. , 2003, Genes & development.
[16] S. Korsmeyer,et al. Caspase Cleaved BID Targets Mitochondria and Is Required for Cytochrome c Release, while BCL-XL Prevents This Release but Not Tumor Necrosis Factor-R1/Fas Death* , 1999, The Journal of Biological Chemistry.
[17] F. Khuri,et al. Protein Farnesyltransferase Inhibitor (SCH 66336) Abolishes NF-κB Activation Induced by Various Carcinogens and Inflammatory Stimuli Leading to Suppression of NF-κB-regulated Gene Expression and Up-regulation of Apoptosis* , 2004, Journal of Biological Chemistry.
[18] C. Erlichman,et al. Synergy of the protein farnesyltransferase inhibitor SCH66336 and cisplatin in human cancer cell lines. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[19] W. Dalton,et al. The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells , 2003, Leukemia.
[20] J. D. Vos,et al. A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells , 2003, Oncogene.
[21] S. Sebti,et al. Design of growth factor antagonists with antiangiogenic and antitumor properties , 2000, Oncogene.
[22] L. Boise,et al. Farnesyl Transferase Inhibitors Enhance Death Receptor Signals and Induce Apoptosis in Multiple Myeloma Cells , 2003, Leukemia & lymphoma.
[23] A. Almasan,et al. Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis , 2000, Cell Death and Differentiation.
[24] Sheo B. Singh,et al. Current progress on farnesyl protein transferase inhibitors. , 2002, Current opinion in drug discovery & development.
[25] Javier Naval,et al. Caspases are the main executioners of Fas-mediated apoptosis, irrespective of the ceramide signalling pathway , 1998, Cell Death and Differentiation.
[26] K. Anderson,et al. CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines. , 2000, Blood.
[27] C. F. Bennett,et al. A Constitutive Cytoprotective Pathway Protects Endothelial Cells from Lipopolysaccharide-induced Apoptosis* , 2001, The Journal of Biological Chemistry.
[28] B. Corfe,et al. Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak , 2001, Oncogene.
[29] J. Cidlowski,et al. Activation of intrinsic and extrinsic pathways in apoptotic signaling during UV-C-induced death of Jurkat cells: the role of caspase inhibition. , 2004, Experimental cell research.
[30] J. Gera,et al. Downstream effectors of oncogenic ras in multiple myeloma cells. , 2003, Blood.
[31] B. Corfe,et al. Cell Damage-induced Conformational Changes of the Pro-Apoptotic Protein Bak In Vivo Precede the Onset of Apoptosis , 1999, The Journal of cell biology.
[32] John Calvin Reed,et al. Detection of multiple antigens on western blots. , 1996, Analytical biochemistry.
[33] R. GonzálezBosch. Treatment of multiple myeloma , 1959 .
[34] R. Kurzrock,et al. Clinical development of farnesyltransferase inhibitors in leukemias and myelodysplastic syndrome. , 2002, Seminars in hematology.
[35] M. Martínez-Lorenzo,et al. Doxorubicin‐induced apoptosis in human T‐cell leukemia is mediated by caspase‐3 activation in a Fas‐independent way , 1997, FEBS letters.
[36] S. Grant,et al. The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells , 2003, Leukemia.
[37] G. Prendergast,et al. Cell Growth Inhibition by Farnesyltransferase Inhibitors Is Mediated by Gain of Geranylgeranylated RhoB , 1999, Molecular and Cellular Biology.
[38] G. Pons,et al. Aspirin induces apoptosis through mitochondrial cytochrome c release , 2000, FEBS letters.
[39] J. Trapani,et al. A new quantitative assay for cytochrome c release in apoptotic cells , 2003, Cell Death and Differentiation.
[40] A. Adjei,et al. Farnesyl transferase inhibitors as anticancer agents. , 2002, European journal of cancer.
[41] M. Urashima,et al. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. , 1997, Journal of immunology.
[42] S. Hilsenbeck,et al. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL. , 2003, Blood.